News

Researchers have developed a microfluidic OvCa-Chip to enable them to investigate the biological processes between ovarian tumors and platelets.

Tiny packages of materials released into the blood called EVPs (extracellular vesicles and particles) may enable detection of a number of different types of cancer in the early stages.

Researchers have discovered which gut bacteria help our immune system battle cancerous tumors and how they do it.

Researchers at Pavol Jozef Šafárik University in Košice, Slovakia, have identified fluorescent molecules in urine that correlate with melanoma progression, creating new possibilities for monitoring the disease.

A team of researchers has revealed key biochemical processes that advance our understanding of colorectal cancer, this knowledge could help in the search for effective anticancer drugs.

Using a new process, scientists can create new nucleoside analogues months earlier than with the previous method, paving the way for quicker drug discoveries.

An analysis of cervical cancers in Ugandan women has uncovered significant genomic differences between tumors caused by different strains of human papillomavirus.

A team of researchers has discovered a dose threshold that greatly increases the delivery of cancer-fighting nanoparticle drugs into a tumor.

Scripps Research chemists Hans Renata, PhD, and Alexander Adibekian, PhD, have discovered a way to efficiently create a synthetic version of a valuable natural compound called cepafungin I, which has shown promise as an anti-cancer agent.

In a paper published in the journal Cancer Research, researchers provide new insights into how ovarian cancer grows and evolves within a person.